SCI
26September
NintedanibplusSildenafilinPatientswithIdiopathicPulmonaryFibrosisKolbMartin,RaghuGanesh,WellsAtholUetal.NintedanibplusSildenafilinPatientswithIdiopathicPulmonaryFibrosis.[J].N.Engl.J.Med.,.
WeillDepartmentofMedicine,WeillCornellMedicalCollege,NewYork–PresbyterianHospitalandWeillCornellMedicalCenter,YorkAve.,Box96,Rm.Y-,NewYork,NY,oratfjm
med.cornell.eduBackground背景Nintedanibisanapprovedtreatmentforidiopathicpulmonaryfibrosis(IPF).Asubgroupanalysisofapreviouslypublishedtrialsuggestedthatsildenafilmayprovidebenefitsregardingoxygenation,gasexchangeasmeasuredbythediffusioncapacityofthelungsforcarbonmonoxide(DlCO),symptoms,andqualityoflifeinpatientswithIPFandseverelydecreasedDlCO.Thatideawastestedinthistrial
Nintedanib是特发性肺纤维化(IPF)的批准治疗方法。先前发表的一项试验的亚组分析表明,西地那非可以提供氧气,气体交换的益处,通过肺部对一氧化碳(DlCO)的扩散能力,症状和IPF患者的生活质量以及严重降低的DlCO来衡量。这个想法在这个试验中进行了测试。
Methods方法Werandomlyassigned,ina1:1ratio,patientswithIPFandaDlCOof35%orlessofthepredictedvaluetoreceivenintedanibatadoseofmgtwicedailyplussildenafilatadoseof20mgthreetimesdaily(nintedanib-plus-sildenafilgroup)ornintedanibatadoseofmgtwicedailyplusplacebothreetimesdaily(nintedanibgroup)for24weeks.TheprimaryendpointwasthechangefrombaselineinthetotalscoreontheSt.George’sRespiratoryQuestionnaire(SGRQ)atweek12(thetotalscorerangesfrom0to,withhigherscoresindicatingworsehealth-relatedqualityoflife).Secondaryendpointsincludedmeasuresofdyspneaandsafety.
我们以1:1的比例随机分配DlCO预测值为35%或更低的IPF患者,一组(nintedanib-plus-sildenafil组)每日两次接受mgnintedanib加每日三次20mg西地那非,一组(nintedanib组)每日两次接受mgnintedanib,加每日三次安慰剂,两组均持续24周。主要终点是第12周St.George’s呼吸问卷(SGRQ)总分从基线的变化(总分从0到,分数越高表明与健康相关的生活质量越差)。次要终点包括呼吸困难和安全性的测量。
Results结果Atotalofpatientsunderwentrandomization.TherewasnosignificantdifferenceintheadjustedmeanchangefrombaselineintheSGRQtotalscoreatweek12betweenthenintedanib-plus-sildenafilgroupandthenintedanibgroup.AbenefitfromsildenafiltreatmentwasnotobservedwithregardtodyspneaasmeasuredwiththeuseoftheUniversityofCalifornia,SanDiego,ShortnessofBreathQuestionnaire.Nonewsafetysignalswereobserved,as白癜风如何控制治疗白癜风的专家
转载请注明地址:http://www.qwhcm.com/zcmbjc/8844.html